Back
Top 0.2%
12.0%
Top 0.6%
12.0%
Top 10%
9.2%
Top 0.2%
8.0%
Top 0.1%
6.5%
#1
6.1%
Top 2%
5.1%
Top 71%
3.2%
Top 16%
2.8%
Top 90%
2.8%
Top 0.9%
2.8%
Top 4%
2.2%
Top 2%
2.0%
Top 0.2%
2.0%
Top 6%
1.4%
Top 2%
1.2%
Top 9%
1.2%
Top 7%
1.0%
Top 18%
1.0%
Top 26%
0.7%
Top 14%
0.7%
Top 12%
0.7%
Top 14%
0.7%
HCMV control in allogeneic stem cell transplant recipients - an analysis of humoral and cellular players beyond antigen-specific T cells in the letermovir era
2025-04-16
hematology
Title + abstract only
View on medRxiv
Show abstract
Allogeneic hematopoietic stem cell transplant (alloSCT) recipients often experience late-onset human cytomegalovirus (HCMV) reactivations following termination of letermovir prophylaxis. Letermovir prophylaxis extends the window for protective B- and T-cell reconstitution; however, our understanding of humoral responses and their contribution to HCMV immune control remains limited. Combining serological and flow cytometric analyses in 42 HCMV-seropositive alloSCT recipients, we herein provide t...
Predicted journal destinations
1
Blood Advances
16 training papers
2
Frontiers in Immunology
140 training papers
3
Nature Communications
483 training papers
4
JCI Insight
63 training papers
5
Journal of Clinical Investigation
50 training papers
6
Cell
28 training papers
7
The Journal of Infectious Diseases
137 training papers
8
Scientific Reports
701 training papers
9
eLife
262 training papers
10
PLOS ONE
1737 training papers
11
Cell Reports Medicine
49 training papers
12
Proceedings of the National Academy of Sciences
100 training papers
13
Nature Medicine
88 training papers
14
Science Advances
52 training papers
15
iScience
74 training papers
16
Science Translational Medicine
40 training papers
17
Nature Genetics
72 training papers
18
Nature
58 training papers
19
Frontiers in Medicine
99 training papers
20
Clinical Infectious Diseases
219 training papers
21
Vaccines
131 training papers
22
eBioMedicine
82 training papers
23
PLOS Computational Biology
141 training papers